Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from https://pubmed.ncbi.nlm.nih.gov/17626705/ below:

An advance notification letter increases participation in colorectal cancer screening

Randomized Controlled Trial

Affiliations

• ¹ Bowel Health Service, Repatriation General Hospital Daw Park, Daw Park, South Australia 5041, Australia. scoles@rgh.sa.gov.au

• PMID: 17626705
• DOI: 10.1258/096914107781261927

Item in Clipboard

Randomized Controlled Trial

S R Cole et al. J Med Screen. 2007.

• ¹ Bowel Health Service, Repatriation General Hospital Daw Park, Daw Park, South Australia 5041, Australia. scoles@rgh.sa.gov.au

• PMID: 17626705
• DOI: 10.1258/096914107781261927

Item in Clipboard

Objectives: To determine the impact of novel invitation strategies on population participation in faecal immunochemical test (FIT)-based colorectal cancer (CRC) screening.

Setting: A community screening programme in Adelaide, South Australia.

Methods: In total, 2400 people aged 50-74 years were randomly allocated to one of four CRC screening invitation strategies: (a)

Control: standard invitation-to-screen letter explaining risk of CRC and the concept, value and method of screening; (b) Risk: invitation with additional messages related to CRC risk; (c) Advocacy: invitation with additional messages related to advocacy for screening from previous screening programme participants and (d) Advance Notification: first, a letter introducing CONTROL letter messages followed by the standard invitation-to-screen. Invitations included an FIT kit. Programme participation rates were determined for each strategy relative to control. Associations between participation and sociodemographic variables were explored.

Results: At 12 weeks after invitation, participation was:

Control: 237/600 (39.5%); Risk: 242/600 (40.3%); Advocacy: 216/600 (36.0%) and Advance Notification: 290/600 (48.3%). Participation was significantly greater than CONTROL only in the Advance Notification group (Relative risk [RR] 1.23, 95% confidence interval [CI] 1.06-1.43). This effect was apparent as early as two weeks from date of offer; Advance Notification: 151/600 (25.2%) versus

Control: 109/600 (18.2%, RR 1.38, 95% CI 1.11-1.73).

Conclusions: Advance notification significantly increased screening participation. The effect may be due to a population shift in readiness to undertake screening, and is consistent with the Transtheoretical Model of behaviour change. Risk or lay advocacy strategies did not improve screening participation. Organized screening programmes should consider using advance notification letters to improve programme participation.

PubMed Disclaimer

• Comparison of mailed invitation strategies to improve fecal occult blood test participation in men: protocol for a randomized controlled trial.

  Duncan A, Zajac I, Flight I, Stewart BJ, Wilson C, Turnbull D. Duncan A, et al. Trials. 2013 Jul 31;14:239. doi: 10.1186/1745-6215-14-239. Trials. 2013. PMID: 23902589 Free PMC article. Clinical Trial.

• Advance notification letters increase adherence in colorectal cancer screening: a population-based randomized trial.

  van Roon AH, Hol L, Wilschut JA, Reijerink JC, van Vuuren AJ, van Ballegooijen M, Habbema JD, van Leerdam ME, Kuipers EJ. van Roon AH, et al. Prev Med. 2011 Jun;52(6):448-51. doi: 10.1016/j.ypmed.2011.01.032. Epub 2011 Mar 30. Prev Med. 2011. PMID: 21457725 Clinical Trial.

• Invitation strategies for colorectal cancer screening programmes: The impact of an advance notification letter.

  Senore C, Ederle A, DePretis G, Magnani C, Canuti D, Deandrea S, Zorzi M, Barca A, Bestagini P, Faitini K, Bisanti L, Casale C, Ferro A, GiorgiRossi P, Quadrino F, Fiorina G, Capuano A, Segnan N, Fantin A. Senore C, et al. Prev Med. 2015 Apr;73:106-11. doi: 10.1016/j.ypmed.2015.01.005. Epub 2015 Jan 17. Prev Med. 2015. PMID: 25602908 Clinical Trial.

• The Effects of Different Invitation Schemes on the Use of Fecal Occult Blood Tests for Colorectal Cancer Screening: Systematic Review of Randomized Controlled Trials.

  Gruner LF, Amitay EL, Heisser T, Guo F, Niedermaier T, Gies A, Hoffmeister M, Brenner H. Gruner LF, et al. Cancers (Basel). 2021 Mar 25;13(7):1520. doi: 10.3390/cancers13071520. Cancers (Basel). 2021. PMID: 33806234 Free PMC article. Review.

• How to increase uptake in oncologic screening: a systematic review of studies comparing population-based screening programs and spontaneous access.

  Ferroni E, Camilloni L, Jimenez B, Furnari G, Borgia P, Guasticchi G, Giorgi Rossi P; Methods to increase participation Working Group. Ferroni E, et al. Prev Med. 2012 Dec;55(6):587-96. doi: 10.1016/j.ypmed.2012.10.007. Epub 2012 Oct 11. Prev Med. 2012. PMID: 23064024 Review.

• Randomized Controlled Trial of Advance Notification Phone Calls vs Text Messages Prior to Mailed Fecal Test Outreach.

  Coronado GD, Nyongesa DB, Petrik AF, Thompson JH, Escaron AL, Younger B, Harbison S, Leo MC. Coronado GD, et al. Clin Gastroenterol Hepatol. 2021 Nov;19(11):2353-2360.e2. doi: 10.1016/j.cgh.2020.07.053. Epub 2020 Jul 30. Clin Gastroenterol Hepatol. 2021. PMID: 32739569 Free PMC article. Clinical Trial.

• Reactions to a targeted intervention to increase fecal occult blood testing among average-risk adults waiting for screening colonoscopy.

  McGregor SE, Ritvo P, Tinmouth J, Kornblum A, Myers R, Hilsden RJ, Paszat LF, Rabeneck L. McGregor SE, et al. Can J Gastroenterol. 2011 May;25(5):248-52. doi: 10.1155/2011/397302. Can J Gastroenterol. 2011. PMID: 21647457 Free PMC article.

• Pre-notification and reminder SMS text messages with behaviourally informed invitation letters to improve uptake of NHS Health Checks: a factorial randomised controlled trial.

  Sallis A, Sherlock J, Bonus A, Saei A, Gold N, Vlaev I, Chadborn T. Sallis A, et al. BMC Public Health. 2019 Aug 22;19(1):1162. doi: 10.1186/s12889-019-7476-8. BMC Public Health. 2019. PMID: 31438908 Free PMC article. Clinical Trial.

• Uptake and positive predictive value of fecal occult blood tests: A randomized controlled trial.

  Chubak J, Bogart A, Fuller S, Laing SS, Green BB. Chubak J, et al. Prev Med. 2013 Nov;57(5):671-8. doi: 10.1016/j.ypmed.2013.08.032. Epub 2013 Sep 9. Prev Med. 2013. PMID: 24029556 Free PMC article. Clinical Trial.

• Using an SMS to improve bowel cancer screening: the acceptability and feasibility of a multifaceted intervention.

  McIntosh JG, Wood A, Jenkins M, Onwuka S, Chondros P, Campbell T, Wenkart E, O'Reilly C, Dixon I, Toner J, Martinez Gutierrez J, Govan L, Emery JD. McIntosh JG, et al. Fam Pract. 2025 Jan 17;42(1):cmae073. doi: 10.1093/fampra/cmae073. Fam Pract. 2025. PMID: 39707155 Free PMC article. Clinical Trial.

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.3